Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 09-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,117 | -6,721 | N/A | N/A | 41,439 |
| Depreciation Amortization | 352 | 91 | N/A | N/A | 39,600 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -9,225 |
| Accounts receivable | N/A | N/A | N/A | N/A | 5,244 |
| Accounts payable and accrued liabilities | 716 | -28 | N/A | N/A | N/A |
| Other Working Capital | 276 | 90 | N/A | N/A | 20,216 |
| Other Operating Activity | -309 | 127 | 0 | 0 | 5,396 |
| Operating Cash Flow | $-15,082 | $-6,441 | $N/A | $N/A | $102,670 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 20,981 |
| PPE Investments | -2,948 | -1,075 | N/A | N/A | -38,620 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -164,662 |
| Purchase Of Investment | -64,633 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-67,581 | $-1,075 | $N/A | $N/A | $-182,301 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 97,884 |
| Debt Repayment | -30 | -72 | N/A | N/A | N/A |
| Common Stock Issued | 115 | 5 | N/A | N/A | 19,572 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -30,621 |
| Other Financing Activity | 104,922 | 16,285 | 0 | 0 | -10,843 |
| Financing Cash Flow | $105,007 | $16,218 | $N/A | $N/A | $75,992 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 827 |
| Beginning Cash Position | 10,226 | 1,524 | N/A | N/A | 43,492 |
| End Cash Position | 32,570 | 10,226 | N/A | N/A | 40,680 |
| Net Cash Flow | $22,344 | $8,702 | $N/A | $N/A | $-2,812 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,082 | -6,441 | N/A | N/A | 102,670 |
| Capital Expenditure | -2,948 | -1,075 | N/A | N/A | -38,620 |
| Free Cash Flow | -18,030 | -7,516 | 0 | 0 | 64,050 |